# SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

> **NCT04647227** · PHASE4 · RECRUITING · sponsor: **American Thrombosis and Hemostasis Network** · enrollment: 55 (estimated)

## Conditions studied

- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor

## Interventions

- **DRUG:** coagulation factor VIIa [recombinant]-jncw

## Key facts

- **NCT ID:** NCT04647227
- **Lead sponsor:** American Thrombosis and Hemostasis Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-28
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-03-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2026-01-12

## Collaborators

- LFB USA, Inc.

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647227, "SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT04647227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*